Sugi Predict

Sugi Predict / Targets / GAR1

GAR1

H/ACA ribonucleoprotein complex subunit 1 · Q9NY12 · GAR1 on Sugi Atlas →

0 patent compounds predicted against GAR1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GAR1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases nanACTIVE_NOT_RECRUITING
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa nanCOMPLETED
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models nanCOMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Study of a Candidate Gene Involved in Goldenhar Syndrome. nanCOMPLETED
Exploring the Genetics of Neuropathic Pain nanRECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Telomere Repair Gene Mutation in Inflammatory Bowel Disease nanCOMPLETED
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GAR1 binder may also engage these)

ProteinNameSimilarity
Q6AYA1 — 1.000 Q6AYA1 →
P28007 — 0.998 P28007 →
Q8VZT0 — 0.997 Q8VZT0 →
Q5RJV1 — 0.997 Q5RJV1 →
Q9CY66 — 0.997 Q9CY66 →
Q7ZVE0 — 0.996 Q7ZVE0 →
Q06975 — 0.994 Q06975 →
P0CN78 — 0.994 P0CN78 →
P0CN79 — 0.994 P0CN79 →
Q757V8 — 0.993 Q757V8 →
Q7KVQ0 — 0.993 Q7KVQ0 →
A1CVY3 — 0.993 A1CVY3 →
Q6BVF9 — 0.993 Q6BVF9 →
Q61B10 — 0.992 Q61B10 →
Q6CJ45 — 0.992 Q6CJ45 →
Q2HH48 — 0.992 Q2HH48 →
Q9TYK1 — 0.992 Q9TYK1 →
Q1E6M1 — 0.991 Q1E6M1 →
A3GHP2 — 0.990 A3GHP2 →
A6SDR8 — 0.989 A6SDR8 →
Q54XE6 — 0.988 Q54XE6 →
Q9FK53 — 0.987 Q9FK53 →
Q6FSB0 — 0.987 Q6FSB0 →
Q4P5P0 — 0.985 Q4P5P0 →
A7VJC2 — 0.971 A7VJC2 →
Q5RBU8 — 0.971 Q5RBU8 →
HNRNPA3 Heterogeneous nuclear ribonucleoprotein A3 0.970 landscape →
Q32P51 — 0.970 Q32P51 →
P48810 — 0.969 P48810 →
Q8BG05 — 0.969 Q8BG05 →